The healthcare provider raised full-year guidance after exceeding Q2 profit and revenue expectations by $0.07 and $20M, respectively.
Encompass Health reported Q2 non-GAAP earnings per share of $1.55, surpassing estimates by $0.07. Revenue reached $1.59 billion, an 8.9% year-over-year increase, beating forecasts by $20 million.
Analysts had anticipated full-year revenue of $6.42 billion and EPS of $6.00. The company’s performance prompted an upward revision to its annual guidance.
Shares showed muted reaction in after-hours trading as investors digested the results and updated projections.